Do you want to read an article? Please log in or register.
Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial
Pneumonia
RECOMMENDED
Related content
RECOMMENDED
Pneumonia
Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Pan J, Guo T, Kong H, Bu W, Shao M, Geng Z
doi: 10.1038/s41598-025-85951-x
Lung Cancer
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial
Lancet Respir Med
Spigel DR, Westeel V, Anderson IC, Greillier L, Guisier F, Bylicki O, Badin FB, Rousseau-Bussac G, Deldycke C, Griesinger F, Bograd A, Zhong W, Le Treut J, Van Hulst S, Gandara DR, Reck M, Hoffknecht P, Gubens MA, Crowley J, von der Leyen H, Woodard GA, Jablons DM, Kratz JR, Mann MJ, AIM-HIGH investigators
doi: 10.1016/S2213-2600(25)00213-9
COMMENTED
Sleep Apnea
Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 0
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Benjafield AV, Pepin JL, Cistulli PA, Wimms A, Lavergne F, Sert Kuniyoshi FH, Munson SH, Schuler B, Reddy Badikol S, Wolfe KC, Willes L, Kelly C, Kendzerska T, Johnson DA, Heinzer R, Lee CH, Malhotra A, medXcloud Group
doi: 10.1016/S2213-2600(25)00002-5
RECOMMENDED
Pneumonia
Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Lansbury L, McKeever TM, Lawrence H, Pick H, Baskaran V, Edwards-Pritchard R, Matthews L, Bailey H, Ashton D, Bendall L, Rodrigo C, Daniel P, Litt D, Eletu S, Parmar H, Sheppard C, Ladhani SN, Trotter C, Lim WS
doi: 10.1136/thorax-2024-221976
RECOMMENDED
Asthma
Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Little P, Vennik J, Rumsby K, Stuart B, Becque T, Moore M, Francis N, Hay AD, Verheij T, Bradbury K, Greenwell K, Dennison L, Holt S, Denison-Day J, Ainsworth B, Raftery J, Thomas T, Butler CC, Richards-Hall S, Smith D, Patel H, Williams S, Barnett J, Middleton K, Miller S, Johnson S, Nuttall J, Webley F, Sach T, Yardley L, Geraghty AWA
doi: 10.1016/S2213-2600(24)00140-1
RECOMMENDED
Pneumonia
Reassessing Halm's clinical stability criteria in community-acquired pneumonia management
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Bastrup Israelsen S, Fally M, Brok Nielsen P, Kolte L, Karmark Iversen K, Ravn P, Benfield T
doi: 10.1183/13993003.00054-2024
COPD
Preventing oxygen desaturation during bronchoscopy in COPD patients using high flow oxygen versus standard management: the randomised controlled PROSA 2 Trial
Eur Respir J
Darie AM, Grize L, Jahn K, Salina A, Röcken J, Herrmann MJ, Pascarella M, Suarez V, Strobel W, Tamm M, Stolz D
doi: 10.1183/13993003.01586-2024
COMMENTED
Asthma
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Castro M, Papi A, Porsbjerg C, Lugogo NL, Brightling CE, González-Barcala FJ, Bourdin A, Ostrovskyy M, Staevska M, Chou PC, Duca L, Pereira AM, Fogarty C, Nadama R, Zhang M, Rodrigues A, Soler X, Sacks HJ, Deniz Y, Rowe PJ, de Prado Gómez L, Jacob-Nara JA
doi: 10.1016/S2213-2600(24)00362-X
RECOMMENDED
Lung Cancer
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [(18)F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Oncol
Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P
doi: 10.1016/S1470-2045(24)00320-6